Active ingredient : Isosorbide dinitrate/Hydralazine Isosorbide dinitrate/Hydralazine
BIDIL is a prescription medication specifically formulated for the treatment of heart failure in certain patients. It combines two active ingredients, hydralazine and isosorbide dinitrate, to help improve blood flow and reduce the workload on the heart. This unique combination works synergistically to enhance the effectiveness of heart failure treatment.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
BIDIL is a prescription medication that combines isosorbide dinitrate and hydralazine. It is primarily used to treat heart failure in specific populations, particularly African American patients. This unique combination works to relax blood vessels, improve blood flow, and reduce the workload on the heart.
The isosorbide dinitrate component dilates blood vessels, which helps to decrease blood pressure and reduce the heart's oxygen demand. Hydralazine, on the other hand, acts as a vasodilator that further aids in lowering blood pressure and improving circulation.
BIDIL is indicated for the treatment of heart failure in conjunction with other medications. It is particularly beneficial for patients who may not respond adequately to standard therapies.
The dosage of BIDIL is individualized based on the patient's response and clinical condition. It is important to follow the prescribing physician's instructions regarding dosage and administration to achieve optimal results.
Common side effects of BIDIL may include headache, dizziness, and gastrointestinal disturbances. More serious side effects can occur, and patients should be monitored for signs of hypotension or allergic reactions.
Before starting BIDIL, patients should inform their healthcare provider of any pre-existing conditions, allergies, or other medications they are taking. Special caution is advised for those with a history of heart conditions or low blood pressure.
BIDIL represents an important treatment option for heart failure, particularly in African American patients. Its combination of isosorbide dinitrate and hydralazine targets multiple pathways involved in heart function, making it a valuable addition to heart failure management strategies.